NCT01000285 EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT00994968 Doxorubicin Hydrochloride, Cyclophosphamide, Docetaxel, and S-1 Before Surgery in Treating Women With Stage II or Stage III Breast Cancer Status UNKNOWN Phase PHASE2
NCT00990496 A Study Using Allogenic-Cytomegalovirus (CMV) Specific Cells for Glioblastoma Multiforme (GBM) Status TERMINATED Phase PHASE1
NCT00983944 Rituximab and Combination Chemotherapy With or Without Bleomycin Sulfate in Treating Patients With Primary Mediastinal Large B-Cell Lymphoma Status WITHDRAWN Phase PHASE2
NCT00981799 Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL Status TERMINATED Phase PHASE1/PHASE2
NCT00977691 Haploidentical PBMC Transplant for Severe Congenital Anemias Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT00976300 Cyclosporine A or Intravenous Cyclophosphamide for Lupus Nephritis: The Cyclofa-Lune Study Status COMPLETED Phase PHASE2
NCT00976131 Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer Status COMPLETED Phase PHASE1
NCT00974792 Combination Chemotherapy and Rituximab in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma Status UNKNOWN Phase PHASE2
NCT00972478 Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT00971763 Gemcitabine Hydrochloride, Cyclophosphamide, Vincristine Sulfate, Prednisolone, and Rituximab in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Status COMPLETED Phase PHASE2
NCT00971737 Cyclophosphamide and Vaccine Therapy With or Without Trastuzumab in Treating Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00968253 RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia Status COMPLETED Phase PHASE1/PHASE2
NCT00963872 Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00963729 Chemotherapy or Letrozole Before Surgery in Treating Postmenopausal Women With Breast Cancer That Can Be Removed By Surgery Status COMPLETED Phase PHASE3
NCT00960063 A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006) Status TERMINATED Phase PHASE1
NCT00959231 Donor Umbilical Cord Blood Transplant After Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease Status UNKNOWN Phase PHASE2
NCT00958854 Fludarabine, Cyclophosphamide, and Thalidomide in Treating Patients With Angioimmunoblastic T-Cell Lymphoma Status UNKNOWN Phase PHASE2
NCT00958256 Study of Bortezomib in Combination With Cyclophosphamide and Rituximab Status COMPLETED Phase PHASE2